Bakiki, Joehmar A.

HRN: 29-23-68  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/01/2026
07/07/2026
IVTT
4.5 G
Q8
Infected Wound With Cellulitis, T/c DKA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: